Friday December 05 2008 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
  • A-Z
 

Proteome Systems Releases New Generation of Intelligent Electrophoresis Solutions

Sydney, Australia, 11 February, 2003 – Proteome Systems today introduced its intelligent electrophoresis platform comprising two innovative and fully integrated systems, IsoelectrIQ2* and ElectrophoretIQ3*. These systems build on well established electrophoresis techniques, integrating cutting edge industrial design and modern information technology giving proteomics researchers easy access to a new level of protein separation and array solutions which will maximize the output from mass spectrometry analysis.

IsoelectrIQ2  features liquid phase isoelectric fractionation and isoelectric focusing in IPGs. ElectrophoretIQ3 features isoelectric focusing in IPGs, second dimension electrophoresis and semi-dry blotting.  The new instruments interface with other Proteome Systems technology in downstream protein digestion and mass spectrometry.  Proteome Systems know-how enhances the high throughput in-gel digestion, sample concentration and desalting prior to mass spectrometry, in the new Millipore Montage® In-Gel DigestZP Kit, including the ZipPlate™ Micro-SPE Plate.  Proteome Systems new refrigerated blotting technology solutions, available on the ElectrophoretIQ3, will interface and support the revolutionary ChIP technology, jointly developed by Proteome Systems and Shimadzu Corporation, which will be available later this year.

The new electrophoresis systems offer computer controlled functionality, advanced multi-channel internal power supplies, cooling, and graphical real-time control and monitoring. They enable high throughput and flexibility by conducting multiple experiments simultaneously with independent control.

Together with a full line of specially designed consumables and kits the systems provide a comprehensive solution for two-dimensional gel electrophoresis. Both systems are network-ready and integrate with Proteome Systems’ informatics solution, BioinformatIQ*, to provide automatic data capture.

Ben Herbert, Executive VP, Technology Development and inventor of these systems said, “after practising electrophoresis for over 17 years I felt it was time for electrophoresis technology to lose the “poor-relation” tag and take on a level of sophistication that is expected in modern scientific equipment. To address this need we brought together experts in electrophoresis, industrial design, engineering and informatics to produce a new generation of intelligent electrophoresis equipment. To obtain the best results, your electrophoresis equipment should integrate within a broader technology platform. I feel that we have achieved that goal and provide proteomics researchers with a technology solution that recognizes the importance of electrophoresis in proteomics”.

For more information and a demonstration visit the ABRF conference, Denver, Colorado, USA, booth 320, or see the website www.electrophoretiq.com

About Proteome Systems
Proteome Systems is a leading proteomics technology, diagnostics and discovery company. With its technology partners, Proteome Systems has developed and commercialized a comprehensive solution for high throughput proteomics, which is available as a total solutions package, ProteomIQ*. These technologies, integrated by a proprietary and sophisticated bioinformatics system, BioinformatIQ, are being marketed as part of a global strategic alliance with IBM. ProteomIQ is implemented in Proteome Systems discovery programs in the areas of cystic fibrosis, cancer, infectious disease and aging. Proteome Systems has R&D and manufacturing facilities in Sydney, Australia and Boston, USA and a joint venture (Proteome Systems Japan) with Itochu Corporation in Tokyo, Japan. Proteome Systems recently formed a joint venture with Charles River Laboratories, Charles River Proteomics Services Inc., Worcester, USA to provide contract services in proteomics.

* IsoelectrIQ2, ElectrophoretIQ3, BioinformatIQ and ProteomIQ are trademarks of Proteome Systems

For more information:
Kirsten Lodge
Corporate Communications
+61 2 8877 8913 office

+61 409 044 674 mobile
kirsten.lodge@proteomesystems.com


BioNews
BioWeb

Companies
Products

BioReports


Search: BioNews | BioWeb | BioCorporate | BioReports | BioEvents
Select:
Advertising & Sponsorship | BioEmail | About BioPortfolio | User Agreement 
Post a:
Job | Resume | Event | Press Release | Company Profile
Add/Link: BioWeb and BioNews on your website
Join:
BioPortfolio's Membership Services | Review our 14 Channels
Receive:
Bulletin | News Email Alerts | DailyUpdates

Copyright © 1997-2006 - BioPortfolio Limited.
All rights reserved. All other trademarks recognized.


Email comments and feedback! 

Peter Barfoot, Managing Director, BioPortfolio Ltd.

USA Voicemail and Fax: 
(+1) 415 680 2472 San Francisco

UK Tel:  (+44) 1300 321501


"who, what, where, when and why biotechnology will impact on our lives"